aapp.org
Open in
urlscan Pro
65.9.66.39
Public Scan
Submitted URL: https://cpnp.org/dm/7986b/9
Effective URL: https://aapp.org/ed/meeting/2023/session/workshop
Submission: On November 14 via api from US — Scanned from DE
Effective URL: https://aapp.org/ed/meeting/2023/session/workshop
Submission: On November 14 via api from US — Scanned from DE
Form analysis
2 forms found in the DOMPOST /search/site
<form id="search" method="post" action="/search/site" accept-charset="UTF-8">
<div class="input-group">
<input id="searchstr" name="keys" type="text" class="form-control" placeholder="Enter search keywords">
<span class="input-group-btn">
<button class="btn btn-danger" type="submit" name="op" value="Search">go</button>
</span>
</div>
<div class="text-right">
<a href="/search/site" class="x-processed-uniqid-1668397984366-5">Advanced search</a>
</div>
</form>
POST /user?destination=node%2F544395
<form accept-charset="UTF-8" class="form-horizontal" role="form" method="post" action="/user?destination=node%2F544395" autocomplete="off">
<div class="row">
<div class="col-sm-12">
<div class="form-group">
<label class="control-label col-sm-3" for="login-name">Email:</label>
<div class="col-sm-9">
<input id="login-name" name="name" type="text" class="form-control">
</div>
</div>
<div class="form-group">
<label class="control-label col-sm-3" for="login-pass">Password:</label>
<div class="col-sm-9">
<input id="login-pass" name="pass" type="password" class="form-control">
</div>
</div>
<div class="form-group">
<div class="col-sm-offset-3 col-sm-9">
<input class="btn btn-danger" name="op" type="submit" value="Sign in">
<a href="/user/password" class="btn btn-default x-processed-uniqid-1668397984366-5">Forgot password</a>
<a href="/user/register?destination=node%2F544395" class="btn btn-default x-processed-uniqid-1668397984366-5">Create new account</a>
</div>
</div>
<div class="row">
<div class="col-sm-offset-3 col-sm-4">
<a href="https://aapp.org/sso/login/linkedin?destination=node%2F544395" class="btn btn-block btn-social btn-linkedin x-processed-uniqid-1668397984366-5"><span class="icon icon-linkedin"></span>Sign in with LinkedIn</a></div>
<div class="col-sm-offset-1 col-sm-4">
<a href="https://aapp.org/sso/login/facebook?destination=node%2F544395" class="btn btn-block btn-social btn-facebook x-processed-uniqid-1668397984366-5"><span class="icon icon-facebook"></span>Sign in with Facebook</a></div>
<div class="form-group"></div>
</div>
</div>
</div>
<input type="hidden" name="form_id" value="user_login">
</form>
Text Content
Toggle navigation Menu Sign in AAPP/CPNP * About Us * Why Psychiatric Pharmacists? * Psychiatric Pharmacists: Improving access, outcomes, and cost * * About AAPP * New Name: American Association of Psychiatric Pharmacists (AAPP) * Celebrating 25 Years! * General Information * Why Join AAPP * AAPP Foundation * Contact AAPP * * Sponsorships * AAPP Member Profile * Corporate Sponsors * Sponsorship Opportunities * * Volunteers and Leaders * Board of Directors * Past Presidents * Committees & Task Forces * * News and Activities * The AAPP Perspective * Awards * Press Releases * Partnerships * * Information for Patients * Toolkits and Resources * Events * AAPP 2023: April 16-19 * AAPP Summit 2022: Oct 6-7 * Residency Showcase, Nov 17-18, 2022 * * Member-Only Virtual Events * Communities Week: Oct 24-26, 2022 * Friday Journal Clubs * * Other Events * Past Events * Future Annual Meetings * Regional/Other Events * * Find More Resources in My CPNP * My CPNP Presentations & Exams * My CPNP ACPE Transcript Center * Education+Resources * Browse by Topic * Opioid Use Disorder * Substance Use Disorders * The AIMS Assessment and Tardive Dyskinesia * USP 800 Compliance * Clozapine: Practice and REMS * Hepatitis C * Comprehensive Medication Management (CMM) * MAOI * Agitation and Aggression * * Browse Continuing Education * Free CE * All online Courses * Psychiatric Pharmacotherapy for Nurses and non-BCPP Pharmacists * * Browse Clinical Resources by Type * The Mental Health Clinician * Treatment Guidelines * Psychiatric Pharmacy Essentials * Medication Database * Position and Endorsed Papers * Resources for Patients and Caregivers * BCPP * My Options * Help Me Choose * * BCPP Exam Preparation * Certification FAQ * Review Book and Prep Series * Registration * * BCPP Recertification * Recertification FAQ * BCPP Recert Products * Review Course with Only ACPE Credit * Registration * * Find More Resources in My AAPP * My Presentations & Exams * My AAPP BCPP Transcript Center * Career/Residency * Choosing Psychiatric Pharmacy * About the Profession * Responsibilities * Practice Settings * Start a Practice * New Practitioner Hub * What I Wish I Knew * * Training Opportunities * Becoming a Psychiatric Pharmacist * Residency Tips * Residency Directory * Fellowships * * Job Opportunities * Job Listings * Post a Job * * Psychiatric Pharmacy Outlook * RPD Survey Results * PGY2 Competency Areas, Goals and Objectives * Members * Join or Renew * Member Toolkit * Member Directory * AAPP Documents and Reports * General Email List * Communities * * Student Resources * Pharmacy Student Hub * Student Chapters * Advocacy * Intro to Psychiatric Pharmacists * Overview and Profiles * See the Research * Presentation Resources * * Advocacy * Health Policy Agenda * Issue Briefs * Letters and Statements * Recent AAPP Papers * Coalitions * Grassroots Advocacy Tools * My AAPP * My AAPP Profile and Preferences * My Profile and Contact Details * Change My Password * Practice Details * Demographics * Communities and Email List * Social Network Profiles * Communication Preferences * Disclosures of Interest * * My AAPP Resources * My Workspaces * My Presentations & Exams * My Posters * My Bookmarks * My Interprofessional Memberships, Presentations, and Activities * * My AAPP Transcript Center * ACPE Transcript * BCPP Transcript * * My AAPP Opportunities * Opportunities Overview * Volunteer Opportunities * Research Opportunities * Scholarly Opportunities * Manage My Posts * * * Sign in go Advanced search Email: Password: Forgot password Create new account Sign in with LinkedIn Sign in with Facebook FAQ • Register (In-Person or Virtual!) • Schedule • Workshop • Posters • Engage/Mentoring • Students • Destination • Sponsorships • Planning Committee • AAPP 2023 ANNUAL MEETING * Contact AAPP * General Information * Destination * FAQs * Planning Committee * Pre-Meeting Workshop (3/1/23) * Posters * Research and Practice Awards * Recertification for the BCPP * Registration * Registration Options * Justification Toolkit * Present a Clinical Pearl * Speakers * Supporters * Sponsorship Opportunities * Product Theater Opportunities * Symposia Opportunities Related Resources AAPP 2023 ANNUAL MEETING * Contact AAPP * General Information * Destination * FAQs * Planning Committee * Pre-Meeting Workshop (3/1/23) * Posters * Research and Practice Awards * Recertification for the BCPP * Registration * Registration Options * Justification Toolkit * Present a Clinical Pearl * Speakers * Supporters * Sponsorship Opportunities * Product Theater Opportunities * Symposia Opportunities HANDS-ON APPROACH TO CARDIOVASCULAR DISEASE RISK MANAGEMENT FOR PEOPLE LIVING WITH MENTAL ILLNESS Bookmark This! REGISTRATION OPTIONS Workshop Date: 3/1/2023 CVD Risk Management Workshop RegistrationMembersNon-membersVirtual Pre-Meeting Workshop: CVD Risk Management$110$120Virtual Pre-Meeting Workshop: CVD Risk Management Fellow/Resident$80$100Virtual Pre-Meeting Workshop: CVD Risk Management Student$50$70 Save $20 when you bundle this virtual workshop with your in-person AAPP 2023 registration. SESSION TIME Date: Wednesday, 03/01/2023 Time: :00 ADT | EDT | CDT | MDT | PDT | AKDT | HST TARGET AUDIENCE If you are a pharmacist, nurse practitioner, or other health care professional providing comprehensive medication management for individuals living with psychiatric disorders, we invite you to participate in this course. SESSION SUMMARY [VIRTUAL WORKSHOP] Individuals with severe mental illness (SMI), such as schizophrenia, bipolar disorder and depression, have an elevated risk of cardiovascular disease (CVD). In addition to the increased prevalence of modifiable risk factors in these populations, many of the medications used in disease management have been linked to weight gain and/or worsening of metabolic cardiovascular risks. Pharmacists are often an underutilized health care resource despite their medication expertise and accessibility. As frontline clinicians, psychiatric pharmacists are trained in the detection and ongoing monitoring of various cardiovascular comorbidities, and are frequently the first to identify such problems. When pharmacists partner with prescribers they are able to take the lead in developing treatment plans, communicating with patients, improving adherence, monitoring patients, identifying treatment options, and performing tasks to alleviate prescriber burden. This workshop will demonstrate different practice settings where psychiatric pharmacists partner with prescribers to provide collaborative care for metabolic disorders in patients with comorbid mental illness. Participants will leave with updated knowledge of current practice standards and treatment strategies for managing comorbid CVD. Furthermore, participants will gain a better understanding of how to incorporate this knowledge into routine practice through the practical application in real-life case scenarios. Agenda (CST) * 1:00-1:10 PM: Welcome and Introductions * 1:10-1:35 PM: Discussion of key guidelines and assessment tools * 1:35-1:45 PM: Small group evaluation of case (focus on guideline application and determining if intervention is warranted for the primary prevention of CVD while considering psychiatric illness) * 1:45-2:00 PM: Reporting results to large group * 2:00-2:10 PM: Break * 2:10-2:35 PM: Discussion of standard treatment approaches and clinical pearls for drug selection in secondary prevention CVD patients * 2:35-2:45 PM: Small group evaluation of case (focus on appropriate treatment selection and level of intervention while considering psychiatric illness in a secondary prevention CVD patient) * 2:45-3:00 PM: Reporting results to large group * 3:00-3:10 PM: Break * 3:10-3:35 PM: Discussion of optimization and ongoing monitoring in vulnerable patient populations * 3:35-3:45 PM: Small group evaluation of case (focus on optimizing treatment and therapeutic goals in vulnerable populations while considering psychiatric illness) * 3:45-4:00 PM: Reporting results to large group * 4:00-4:15 PM: Q&A COURSE REQUIREMENTS To receive ACPE credit for this session, you must: * Sign in (or create a FREE account). * Register for this course. * Review the full content of the activity and reflect upon its teachings. * Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript. View System Requirements to Access All Session Resources AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need: * A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended , or the latest version of Firefox or Safari. * A PDF reader: Chrome built-in, Firefox built-in, Acrobat or FoxIt AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 7 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience. FACULTY INFORMATION AND DISCLOSURES Sarah Anderson PharmD, BCACP, BCPS, FASHP, FCCP Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, FAHA, FASHP, FCCP, FNLA View biographical information and disclosures Sarah Anderson PharmD, BCACP, BCPS, FASHP, FCCP Scientific Director Clinical Care Options Denver, CO This presentation will not include discussion of off-label, experimental, and /or investigational use of drugs or devices. Financial/Stock Interests: Previously owned stock in Abbott Laboratories, Becton & Dickinson, Johnson & Johnson, and Merck & Co. Other: Served on ad board of Portola Pharmaceuticals (12/2019) Dr. Anderson earned her Bachelor of Arts degree in Biochemistry from the University of Colorado at Boulder and her Doctor of Pharmacy degree from the University of Colorado School of Pharmacy. Following completion of her PharmD degree, Dr. Anderson completed a PGY1 Pharmacy Practice Residency at Denver Health Medical Center and a PGY2 Ambulatory Care/Family Medicine Residency at the University of Colorado School of Pharmacy. Dr. Anderson has 12 years of experience in academia and clinical practice. She has served as a Visiting Associate Professor for the University of Colorado School of Medicine’s Child Health Associate/Physician Assistant (CHA/PA) program and was previously a full-time Associate Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in the Department of Clinical Pharmacy. Dr. Anderson practiced for 12 years at the Denver Health Medical Center Eastside Adult Internal Medicine Clinic, with a focus on cardiology and cardiometabolic disease states. Currently, Dr. Anderson is a Scientific Director at Clinical Care Options (CCO), a division of Clinical Education Alliance. In her role, Dr. Anderson is responsible for development of live and online medical education programs, including national and international faculty management, content creation, content editing, content preparation for online and print production, and assisting in development of marketing materials. Dr. Anderson is highly involved in ASHP, ACCP, and the Colorado Pharmacists Society. Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, FAHA, FASHP, FCCP, FNLA Ambulatory Pharmacy Clinical Coordinator, Billings Clinic; Visiting Clinical Associate Professor, University of Colorado School of Medicine Billings, MT No Relevant Financial Relationships to Disclose Dr. Marrs earned his Doctor of Pharmacy degree from Butler University and his Master of Public Health focused on Epidemiology from the University of Colorado Anschutz Medical Campus, Colorado School of Public Health. Following completion of his PharmD degree, Dr. Marrs completed a PGY1 Pharmacy Practice Residency with Mount Carmel Medical Center in Columbus, Ohio and a PGY2 Ambulatory Care/Family Medicine Residency at the University of Colorado School of Pharmacy. Dr. Marrs has 15 years of experience in academia and clinical practice. He serves as a Visiting Associate Professor for the University of Colorado School of Medicine’s Child Health Associate/Physician Assistant (CHA/PA) program where he coordinates their pharmacology curriculum and performs research in the areas of cardiovascular disease. He previously was a full-time Associate Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in the Department of Clinical Pharmacy and prior to that faculty position he was a full-time faculty member with the Oregon State University/Oregon Health & Science University College of Pharmacy. While on faculty at University of Colorado School of Pharmacy Dr. Marrs practiced for 12 years at the Denver Health Medical Center Eastside Adult Internal Medicine Clinic, with a focus on cardiology and cardiometabolic disease states. Currently, Dr. Marrs is an Ambulatory Pharmacy Clinical Coordinator with Billings Clinic. In his role, Dr. Marrs is responsible for leading a team of ambulatory clinical pharmacists in primary care (Family/Internal Medicine) and specialty care (Cardiology, Neurology, Oncology, and Pediatrics). He works with the team in developing, refining, and reporting on clinical and financial metrics and justifying clinical pharmacy services. Further he continues to support his team with training pharmacy students and residents in the ambulatory setting. Dr. Marrs is a fellow of the AHA, ACCP, ASHP, and NLA and continues to be highly involved in all these organizations. LEARNING OBJECTIVES 1. Review key recommendations from essential guidelines for the management of common cardiovascular diseases (CVDs). 2. Apply various risk assessment tools to determine which patients require intervention. 3. Describe current pharmacologic approaches for the management of CVD in a patient with mental illness. 4. Identify strategies to achieve optimal outcomes in patients with CVD and mental illness. 5. Select an appropriate monitoring plan for a patient with CVD to determine if treatment goals are being met. CONTINUING EDUCATION CREDIT AND DISCLOSURES Workshop Date: 3/1/2023 ACPE Contact Hours: 3 ACPE Number: 0284-0000-23-001-L01-P (Application) Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal. The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. View planning committee disclosures 2022 Program Committee Elayne D. Ansara, PharmD, BCPP, BCPS Clinical Pharmacy Specialist Veteran Health Indiana Indianapolis, IN No Relevant Financial Relationships to Disclose Jolene R. Bostwick, PharmD, BCPP, BCPS Program Administrative Chair Assistant Dean for Co-Curriculum and Professional Development & Clinical Professor University of Michigan College of Pharmacy Ann Arbor, MI No Relevant Financial Relationships to Disclose Bridget Bradley, PharmD, BCPP Associate Professor Pacific University School of Pharmacy Hillsboro, OR External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: ACCP PSAP May 2021, Neurology and Psychiatry Book Educational Grants, Research Grants or Contracts: NACDS Community Pharmacy Residency Grant Austin R. Campbell, PharmD, BCPP Program Committee Chair Clinical Pharmacy Specialist - Psychiatry University of Missouri Health Care Columbia, MO External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Sunovion Pharmaceuticals Inc. Speakers Bureau Financial Interests: Up To Date Contributor "Pharmacotherapy for schizophrenia: Long-acting injectable antipsychotic drugs" Non-Financial Interests: Extension for Community Healthcare Outcomes, Show-Me ECHO Project Chelsea N. Carr, PharmD, BCPP Advanced Practice Pharmacist - Psychiatry University of Maryland School of Pharmacy Catonsville, MD No Relevant Financial Relationships to Disclose Dana Chiulli, PharmD, BCPP Clinical Pharmacist - Mental Health VISN 06 Mental Health Clinical Resource Hub Savannah, GA No Relevant Financial Relationships to Disclose Jordan Cooler, PharmD, BCPP Clinical Assistant Professor University of South Carolina College of Pharmacy Columbia, SC No Relevant Financial Relationships to Disclose Bennett J. Doughty, PharmD, BCPP, BCPS Clinical Assistant Professor Binghamton University School of Pharmacy and Pharmaceutical Sciences Binghamton, NY External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Achieve CE - CE provided for compensation Educational Grants, Research Grants or Contracts: SUNY Germination Space Grant. $50,000. Awarded July 2019. Non-Financial Interests: New York State American College of Clinical Pharmacists Executive Board Amber R. Douglass, PharmD, BCPS, BCPP Clinical Pharmacy Specialist - Mental Health VISN 1 Clinical Resource Hub - VA Connecticut Healthcare System West Haven, CT No Relevant Financial Relationships to Disclose Megan J. Ehret, PharmD, BCPP, MS BCPP Program Director Professor University of Maryland Baltimore, MD External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Psych U Section Advisor, Lexi-Comp Consultant/Reviewer Educational Grants, Research Grants or Contracts: FDA/University of Maryland CERSI, Maryland Behavioral Health Department, NIH Kristen N. Gardner, PharmD, BCPP Clinical Pharmacy Specialist - Behavioral Health Kaiser Permanente Colorado Denver, CO External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Biostrategies - one time consultant re:LAIAs (2019) Educational Grants, Research Grants or Contracts: ACCP PSAP author (2021-2022); ACCP annual meeting speaker (2020) Michelle L. Geier, PharmD, BCPP Psychiatric Clinical Pharmacist Supervisor San Francisco Department of Public Health San Francisco, CA External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Weitzman Institute Project ECHO Faculty Nicole Hahn, PharmD, BCACP Clinical Pharmacy Specialist - Neurology Kaiser Permanente Denver, CO No Relevant Financial Relationships to Disclose Kayla D. Johnson, PharmD, BCPP, BCPS Vanderbilt University Medical Center Thompsons Station, TN No Relevant Financial Relationships to Disclose Erin D. Knox, PharmD, BCPP Director of Experiential Education UCI School of Pharmacy & Pharmaceutical Sciences Irvine, CA Non-Financial Interests: Santa Ana Community College, Pharmacy Technology Program, Advisory Committee Marketa Marvanova, PharmD, PhD, BCGP, BCPP, FASCP Dean and Professor University of Montana, Skaggs School of Pharmacy Missoula, MT External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Editorial Board member: Continuum: Lifelong Learning in Neuroilogy, consultant for Lexicomp as a clinical specialist in neurology and psychiatry Melissa Mitchell, PharmD, BCGP, BCPP, BCPS Senior Clinical Pharmacist RUHS MC Moreno Valley , CA External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Neurocrine Speakers Bureau - Ingrezza, Janssen Speakers Bureau - Spravato, Otsuka - PsychU.org Speaker Thea R. Moore, PharmD, BCPP Associate Professor University of South Florida Tampa, FL No Relevant Financial Relationships to Disclose Lindsey Peters, PharmD, BCPS Associate Professor of Pharmacy Practice Ohio Northern University Ada, OH No Relevant Financial Relationships to Disclose Kristina Reinstatler, PharmD, BCPP, MBA Clinical Pharmacy Specialist UC Health University of Cincinnati Medical Center Cincinnati, OH Educational Grants, Research Grants or Contracts: HEALing Communities NIH grant- pharmacy lead Athens Cty, Ohio Michael D. Shuman, PharmD, BCPP Staff Pharmacist Central State Hospital Lousiville, KY No Relevant Financial Relationships to Disclose Taylor A. Thomas, PharmD, BCPP Clinical Pharmacy Specialist- Mental Health VA Northern Indiana Health Care System Fort Wayne, IN No Relevant Financial Relationships to Disclose Nina Vadiei, PharmD, BCPP Assistant Professor University of Arizona Colleges of Pharmacy and Medicine Tucson, AZ No Relevant Financial Relationships to Disclose All relevant relationships have been mitigated. View disclaimer and disclosure of off-label use Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. View fair balance and integrity statement It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems. Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified. ABOUT AAPP The American Association of Psychiatric Pharmacists (AAPP) represents about 3,000 health care professionals. As members of a treatment team of health care professionals, psychiatric pharmacists make a difference in patient recovery and quality of life. HIGHLIGHTS * AAPP 2023 Annual Meeting * AAPP Summit 2022 * BCPP Resources * Education + Resources * The Mental Health Clinician * The AAPP Perspective * AAPP Foundation * Business Opportunities MY AAPP * Site Search: Locate Resources * My Profile * My BCPP Transcript * My Presentations and Exams * Communities Lunch and Learn Webinars * Opportunities for Involvement CONTACT AAPP 8055 O Street Suite S113 Lincoln, NE 68510 T: 402-476-1677 info@aapp.org © 2003-2022 aapp.org | All Rights Reserved | Terms of Use | Contact Got it! AAPP websites use cookies to personalize and enhance your experience. By continuing to use the site, you agree to this collection. Learn more. 25 Years! × SEND AN EMAIL You have clicked a link to send an email. If your email program does not launch automatically, then you can copy-paste the email address(es) below into a new email. info@aapp.org